Best practice tips for selecting a prepared media supplier
What does a good supplier look like? Andrew Ramage, Microbiology Product Specialist at Cherwell Laboratories, advises how to take the guesswork out of the search.
Any businesses requiring prepared media for microbiological testing activities, such as environmental monitoring, need to know two things: that all media is guaranteed to be of high quality and offer reliable results; and that confidence in the supplier is rooted in provable standards, certifications and validated processes.
Researching potential suppliers is, of course, essential, but where do you start with understanding what a good supplier looks like? There are many factors to consider - from their media manufacture processes, storage and transport to their depth of technical knowledge, and the kind of relationship you can expect to nurture.
Best practice tips for finding suppliers:
Once you have your own criteria mapped out, here are the key questions for your shortlisted potential suppliers:
Cherwell Laboratories, specialist suppliers of products for environmental monitoring and process validation, has published an eBook: The Pharmaceutical and Cleanroom Industry’s Pocket Guide to Prepared Culture Media. The guide, which is intended for anyone involved in using and/or buying microbiological media, aims to provide an understanding of the best practices and breadth of prepared culture media options for varying applications within the pharmaceutical and cleanroom industry.
The comprehensive guide equips the reader with all the information they need to consider in order to produce; purchase; store and use prepared media effectively. Focusing on the key topics covered in the guide will help readers to ensure their culture media is of a consistently high quality to deliver reliable results that they can be confident of, every time.
Topics within the guide include: an overview of the various applications of prepared media; best practice guidelines for handling and storing prepared media; the logistics of in-house prepared media manufacture; the argument for pre-prepared media versus in-house manufacturing and guidelines on how to choose a prepared media supplier.
Commenting on the eBook, Andrew Ramage says: “I hope this booklet will educate and inform the reader of the many considerations needed to manufacture high-quality microbiological growth media. A flexible and reliable manufacturer of prepared media will be able to guarantee the customer receives exactly the product they require, to a consistently high standard. Once the reader has finished reading this booklet they should also have a clearer understanding of the pros and cons of buying in prepared media versus manufacturing in-house.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance